---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-057267"
form_type: "8-K"
ticker: "INCY"
cik: "0000879169"
company_name: "INCYTE CORP"
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T15:14:52.422690+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Incyte appoints Dr. Pablo J. Cagnoni as President, R&D, effective June 5, 2023

## Summary
- Board approved appointment of Pablo J. Cagnoni, M.D. as President, Research and Development on May 4, 2023.
- Appointment becomes effective June 5, 2023.
- No other executive changes or succession details disclosed in filing.

## SEC filing metadata
- accession: 0001104659-23-057267
- form_type: 8-K
- ticker: INCY
- cik: 0000879169
- company_name: INCYTE CORP
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/879169/000110465923057267/0001104659-23-057267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/879169/000110465923057267/tm2315067d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-057267
- JSON: https://secwatch.observer/filing/0001104659-23-057267.json
- Plain text: https://secwatch.observer/filing/0001104659-23-057267.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.